Altimmune, Inc. (ALT)

Altimmune Market Cap

Altimmune has a market cap or net worth of $674.58 million as of January 28, 2026. Its market cap has increased by 27.30% in one year.

• Market Cap: 674.58M
• Enterprise Value: 479.71M
• 1-Year Change: 27.30%
• Ranking: #2855
• Category: Small-Cap
• Stock Price: $6.18

Market Cap Chart

Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $674.58M, an increase of 727.70%. That is a compound annual growth rate of 10.96%.

Market Cap History

Date	Market Cap	% Change
Jan 26, 2026	590.10M	56.77%
Dec 31, 2025	376.40M	-26.60%
Dec 31, 2024	512.80M	-15.16%
Dec 29, 2023	604.40M	-25.26%
Dec 30, 2022	808.70M	122.17%
Dec 31, 2021	364.00M	-2.41%
Dec 31, 2020	373.00M	1,186.21%
Dec 31, 2019	29.00M	61.11%
Dec 31, 2018	18.00M	-42.12%
Dec 29, 2017	31.10M	-85.66%
Dec 30, 2016	216.90M	77.06%
Dec 31, 2015	122.50M	6.80%
Dec 31, 2014	114.70M	17.88%
Dec 31, 2013	97.30M	79.52%
Dec 31, 2012	54.20M	-11.58%
Dec 30, 2011	61.30M	-64.57%
Dec 31, 2010	173.00M	210.59%
Dec 31, 2009	55.70M	-6.39%
Dec 31, 2008	59.50M	-31.77%
Dec 31, 2007	87.20M	1.04%
Dec 29, 2006	86.30M	4.10%
Dec 30, 2005	82.90M	1.72%
Oct 6, 2005	81.50M	-

View and export this data all the way back to 2005. Sign Up Today.

Related Stocks

Company	Market Cap
Gyre Therapeutics	735.30M
Cullinan Therapeutics	729.00M
Fulcrum Therapeutics	721.71M
REGENXBIO	678.86M
Rigel Pharmaceuticals	676.14M
ProKidney	664.84M
MeiraGTx Holdings	644.73M
Forte Biosciences	633.55M